Efficacy Of Cancer Treatments - Toxicology

Relevant Publications

Systemic oncological therapy in breast cancer patients on dialysis.

Issue Release: 2024

BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC.

Issue Release: 2024

PCCA variant rs16957301 is a novel AKI risk genotype-specific for patients who receive ICI treatment: Real-world evidence from All of Us cohort.

Issue Release: 2024

Biodegradable Microembolics with Nanografted Polyanions Enable High-Efficiency Drug Loading and Sustained Deep-Tumor Drug Penetration for Locoregional Chemoembolization Treatment.

Issue Release: 2024

A Visual Analysis of the Research Dynamics in Resistance to EGFR Inhibitors for NSCLC.

Issue Release: 2024

Fabrication of pH-responsive temozolomide (TMZ)-clacked tannic acid-altered zeolite imidazole nanoframeworks (ZIF-8) enhance anticancer activity and apoptosis induction in glioma cancer cells.

Issue Release: 2024

Nonoperative management and local excision after neoadjuvant chemoradiation therapy for rectal cancer.

Issue Release: 2024

Update on iron supplementation in patients with cancer-related anemia.

Issue Release: 2024

Potential applications of antofine and its synthetic derivatives in cancer therapy: structural and molecular insights.

Issue Release: 2024

The most recent progress of baicalein in its anti-neoplastic effects and mechanisms.

Issue Release: 2024

Artificial INtelligence to Support Informed DEcision-making (INSIDE) for Improved Literature Analysis in Oncology.

Issue Release: 2024

Thymol as adjuvant in oncology: molecular mechanisms, therapeutic potentials, and prospects for integration in cancer management.

Issue Release: 2024

Tumor microenvironment characteristics of lipid metabolism reprogramming related to ferroptosis and EndMT influencing prognosis in gastric cancer.

Issue Release: 2024

Advances in SHP2 tunnel allosteric inhibitors and bifunctional molecules.

Issue Release: 2024

Specific microbiome patterns and their association with breast cancer: the intestinal microbiota as a potential biomarker and therapeutic strategy.

Issue Release: 2024

Tauroursodeoxycholic Acid Reverses Dextran Sulfate Sodium-Induced Colitis in Mice via Modulation of Intestinal Barrier Dysfunction and Microbiome Dysregulation.

Issue Release: 2024

Understanding the dynamics of TKI-induced changes in the tumor immune microenvironment for improved therapeutic effect.

Issue Release: 2024

Nanoparticle-mediated thermal Cancer therapies: Strategies to improve clinical translatability.

Issue Release: 2024

Photothermal and radiotherapy with alginate-coated gold nanoparticles for breast cancer treatment.

Issue Release: 2024

Capecitabine monotherapy as first-line treatment in advanced HER2-normal breast cancer - a nationwide, retrospective study.

Issue Release: 2024

How Does the Act Impact Toxicology?

What Are the Strategies for Reducing VOC Exposure?

What Are the Health Impacts of These Sources?

What is the Future of Drug Delivery in Toxicology?

How Does Mercury Affect Human Health?

What Are the Future Directions in Toxicological Evaluations?

What Are the Risk Factors for Hepatotoxicity?

What is Asbestos and Why is it Hazardous?

How Do Enantiomers Affect Drug Efficacy and Safety?

How Can Toxicologists Get Involved with COS?

Partnered Content Networks

Relevant Topics